1.At the Time of Revision of the Pharmaceutical Law.
Journal of the Korean Medical Association 2001;44(5):458-459
No abstract available.
Jurisprudence*
2.Why the Policy of Sparation of Dispensary Be Abolished?.
Journal of the Korean Medical Association 2002;45(10):1170-1173
No abstract available.
3.Diagnostic Usefulness of Immunoblot Assay in Autoimmune Bullous Dermatoses.
Korean Journal of Immunology 1997;19(1):129-134
Immunologic or immunopathologic assays are neccesary for the diagnosis of autoimmune bullous dermatoses including pemphigus vulgaris (PV), bullous pemphigoid (BP), and epidermolysis bullosa acquisita (EBA). The objectives of this study is to compare the sensitivity and usefulness of indirect immunofluorescence 0F) with that of immunoblot assay using amplified alkaline phosphatase staining system in the diagnosis of the above diseases; detection of disease-specific IgG autoantibodies. We selected 4 patients in each bullous dermatosis of PV, BP, and EBA, who had serum levels of IgG autoantibodies at a titer of 1:80 or higher. In each three disease, 2 patients with negative serum antibodies or serum titer lower than 1:20, were also enrolled. Among the former 4-patient groups the titers of IgG antibodies found on indirect IF were in the range of 1:80 to 1:160, whereas the titers recognized by immunoblot assay were 1 or 2 dilutions higher in most of these patients. In the latter 2-patient groups, 4 out of the 6 cases revealed antibody-positive on immunoblot-staining membrane. The indirect IF can be performed easily and seems favorable in the aspect of cost-effectiveness. However, immunoblot assay with sensitive staining method would be warranted in cases of antibody-negative or atypical clinical variants of autoimmunebullous dermatoses to confirm the diagnosis.
Alkaline Phosphatase
;
Antibodies
;
Autoantibodies
;
Diagnosis
;
Epidermolysis Bullosa Acquisita
;
Fluorescent Antibody Technique, Indirect
;
Humans
;
Immunoglobulin G
;
Membranes
;
Pemphigoid, Bullous
;
Pemphigus
;
Skin Diseases
;
Skin Diseases, Vesiculobullous*
4.Editor's Letter.
Journal of Korean Neuropsychiatric Association 2012;51(1):3-3
No abstract available.
5.Lamivudine therapy for type B chronic hepatitis in Korea.
Korean Journal of Medicine 2000;58(4):374-377
No abstract available.
Hepatitis, Chronic*
;
Korea*
;
Lamivudine*
6.Clinical Features of Epidermolysis Bullosa Acquisita.
Annals of Dermatology 1996;8(2):85-89
Epidermolysis bullosa acquisita (EBA) is an autoimmune blistering disease of the skin occurring mostly in middle-aged persons with characteristic skin lesions of inflammatory in a vesiculobullae and mechanobullous lesions. Separation of the skin occurs at the dermoepidermal junction (DEJ) initiated by an immune process involving the anchoring fibrils (AF) 764, which have a role in the normal adherence of the epidermis and the dermis. Patients with EBA have autoantibodies of IgG to type VII collagen which is the main component of AF. An electron microscopic. picture of normal DEJ is shown in figure 1, and the antigen site 2011s of this disease (AF) is noted at the upper-most part of the dermis. In EBA, a biopsy specimen shows subepidermal bulla with a variable degree of dermal in-filtrates. Immunofluorescence (IF) demonstrates a linear deposit of IgG. The pattern of immune deposits along the DEJ is similar to that of bullous pemphigoid. However, the linear iing. fashion is thicker and coarser. When examined by the indirect method with a semi-horizontal section of normal human skin substrates the same patterns can be observed: a fine linear deposit with bullous pemphigoid antibodies and a slightly coarser linear pattern with EBA antibodies. With salt-split skin substrates, the serum autoantibodies of IgG are found to be bound only to the dermal side, the AF zone (Fig. 2). This immunopathologic study can provide a diagnostic finding. Transmission electron microscopic examination reveals blister to be localized just beneath the lamina densa, the site of the immune deposit. In immunoblot analysis of the patient's serum against the. dermal extracts, serum antibodies are found to recognize type VII collagen of 290/145 kD (Fig. 3). This is a confirmatory technique (with antibody-positive sera) in the diagnosis of EBA.
Antibodies
;
Autoantibodies
;
Biopsy
;
Blister
;
Collagen Type VII
;
Dermis
;
Diagnosis
;
Epidermis
;
Epidermolysis Bullosa Acquisita*
;
Epidermolysis Bullosa*
;
Fluorescent Antibody Technique
;
Humans
;
Immunoglobulin G
;
Methods
;
Pemphigoid, Bullous
;
Skin
7.Immunofluorescent Studies of Erythema Nodosum Leprosum.
Korean Journal of Dermatology 1982;20(6):819-825
Skin lesions of erythema nodosum leprosum(ENL) occurs as crops of erythematous papules with microscopical features of vasculitis, and these are considered to he immune complex mediated. Recent studies by several investigators detected high levels of circulating immune complexes in over fifty percent of patients with ENL, using well known Clq binding assay or monoclonal rheumatoid factor assay. Moreover they found immuoglobulins (Ig) and complement components in the blood vessels of these patients. These immunopathologic data presented more support to the immune complex mediated pathogenesis of the skin lesions in ENL spectrum. In connection with these findings, examinations of the skin lesions of Korean patient with ENL by immunofluorescent techniques were done. Among seven biopsy specimens from each seven patients, four revealed deposits of Igs (G and M) along with CR in dermal blood vesseIs. Alpha-1 antitrypsin and fibrin were also found in some patients.
Antigen-Antibody Complex
;
Biopsy
;
Blood Vessels
;
Complement System Proteins
;
Erythema Nodosum*
;
Erythema*
;
Fibrin
;
Humans
;
Research Personnel
;
Rheumatoid Factor
;
Skin
;
Vasculitis
8.Recent Advances in Radiation Therapy of Lung Cancer.
Tuberculosis and Respiratory Diseases 2000;49(6):665-675
No abstract available.
Lung Neoplasms*
;
Lung*
9.Preventin of Hepatitis B.
Journal of the Korean Pediatric Society 1983;26(5):421-427
No abstract available.
Hepatitis B*
;
Hepatitis*
10.Current Antiviral Therapy of Chronic Hepatitis B and C.
Journal of the Korean Medical Association 1999;42(9):898-906
No abstract available.
Hepatitis B, Chronic*
;
Hepatitis, Chronic*